|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yegin EG, Oymaci E, Karatay E and Coker A:
Progress in surgical and nonsurgical approaches for hepatocellular
carcinoma treatment. Hepatobiliary Pancreat Dis Int. 15:234–256.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buendia MA and Neuveut C: Hepatocellular
carcinoma. Cold Spring Harb Perspect Med. 5:a0214442015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeng YE, Yao XH, Yan ZP, Liu JX and Liu
XH: Potential signaling pathway involved in
sphingosine-1-phosphate-induced epithelial-mesenchymal transition
in cancer. Oncol Lett. 12:379–382. 2016.PubMed/NCBI
|
|
6
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin Z, Li JW, Wang Y, Chen T, Ren N, Yang
L, Xu W, He H, Jiang Y, Chen X, et al: Abnormal miRNA-30e
expression is associated with breast cancer progression. Clin Lab.
62:121–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Chen J, Lin Z, Cao J, Huang H,
Jiang Y, He H, Yang L, Ren N and Liu G: Role of deregulated
microRNAs in non-small cell lung cancer progression using
fresh-frozen and formalin-fixed, paraffin-embedded samples. Oncol
Lett. 11:801–808. 2016.PubMed/NCBI
|
|
12
|
Feng G, Shi H, Li J, Yang Z, Fang R, Ye L,
Zhang W and Zhang X: MiR-30e suppresses proliferation of hepatoma
cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1)
mRNA. Biochem Biophys Res Commun. 472:516–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong CM, Wong CC, Lee JM, Fan DN, Au SL
and Ng IO: Sequential alterations of microRNA expression in
hepatocellular carcinoma development and venous metastasis.
Hepatology. 55:1453–1461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhattacharya S, Steele R, Shrivastava S,
Chakraborty S, Di Bisceglie AM and Ray RB: Serum miR-30e and
miR-223 as novel noninvasive biomarkers for hepatocellular
carcinoma. Am J Pathol. 186:242–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yi Z, Fu Y, Ji R, Li R and Guan Z: Altered
microRNA signatures in sputum of patients with active pulmonary
tuberculosis. PLoS One. 7:e431842012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
17
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM,
Wu JY, Chen HY, Wang ZW, Qiu GQ and Peng ZH: Identification of
recurrence-related microRNAs in hepatocellular carcinoma following
liver transplantation. Mol Oncol. 6:445–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bertero T, Grosso S, Robbe-Sermesant K,
Lebrigand K, Hénaoui IS, Puisségur MP, Fourre S, Zaragosi LE,
Mazure NM, Ponzio G, et al: ‘Seed-Milarity’ confers to hsa-miR-210
and hsa-miR-147b similar functional activity. PLoS One.
7:e449192012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Uhlmann S, Mannsperger H, Zhang JD, Horvat
EÁ, Schmidt C, Küblbeck M, Henjes F, Ward A, Tschulena U, Zweig K,
et al: Global microRNA level regulation of EGFR-driven cell-cycle
protein network in breast cancer. Mol Syst Biol. 8:5702012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang F, Zhang H, Xu N, Huang N, Tian C, Ye
A, Hu G, He J and Zhang Y: A novel hypoxia-induced miR-147a
regulates cell proliferation through a positive feedback loop of
stabilizing HIF-1α. Cancer Biol Ther. 17:790–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng L, Deng CL, Wang L, Huang XB, You N,
Tang YC, Wu K, Liang P, Mi N and Li J: COMMD7 is correlated with a
novel NF-κB positive feedback loop in hepatocellular carcinoma.
Oncotarget. 7:32774–32784. 2016.PubMed/NCBI
|
|
23
|
Zeng Y, Sun HR, Yu C, Lai Y, Liu XJ, Wu J,
Chen HQ and Liu XH: CXCR1 and CXCR2 are novel mechano-sensors
mediating laminar shear stress-induced endothelial cell migration.
Cytokine. 53:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, Bolondi L and Negrini M: MicroRNA
involvement in hepatocellular carcinoma. J Cell Mol Med.
12:2189–2204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin X, Yang Z, Zhang P, Liu Y and Shao G:
miR-154 inhibits migration and invasion of human non-small cell
lung cancer by targeting ZEB2. Oncol Lett. 12:301–306.
2016.PubMed/NCBI
|
|
27
|
Barcelona PF, Ortiz SG, Chiabrando GA and
Sánchez MC: Alpha2-macroglobulin induces glial fibrillary acidic
protein expression mediated by low-density lipoprotein
receptor-related protein 1 in Müller cells. Invest Ophthalmol Vis
Sci. 52:778–786. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang P, Gu Y, Zhang Q, Han Y, Hou J, Lin
L, Wu C, Bao Y, Su X, Jiang M, et al: Identification of resting and
type I IFN-activated human NK cell miRNomes reveals microRNA-378
and microRNA-30e as negative regulators of NK cell cytotoxicity. J
Immunol. 189:211–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma S, Liu M, Xu Z, Li Y, Guo H, Ge Y, Liu
Y, Zheng D and Shi J: A double feedback loop mediated by
microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage
polarization and thus regulates cancer progression. Oncotarget.
7:13502–13519. 2016.PubMed/NCBI
|
|
30
|
Su R, Dong L, Zou D, Zhao H, Ren Y, Li F,
Yi P, Li L, Zhu Y, Ma Y, et al: microRNA-23a, −27a and −24
synergistically regulate JAK1/Stat3 cascade and serve as novel
therapeutic targets in human acute erythroid leukemia. Oncogene.
35:6001–6014. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuang G, Wu X, Jiang Z, Kasman I, Yao J,
Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, et al:
Tumour-secreted miR-9 promotes endothelial cell migration and
angiogenesis by activating the JAK-STAT pathway. EMBO J.
31:3513–3523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Q, Huang C, Yang Q, Gao L, Liu HC,
Tang J and Feng WH: MicroRNA-30c modulates type I IFN responses to
facilitate porcine reproductive and respiratory syndrome virus
infection by targeting JAK1. J Immunol. 196:2272–2282. 2016.
View Article : Google Scholar : PubMed/NCBI
|
